Exhibit 99.1

                Ibis Technology Receives Nasdaq Notice
                   Regarding Minimum Bid Price Rule


    DANVERS, Mass.--(BUSINESS WIRE)--Dec. 12, 2007--Ibis Technology
Corporation (Nasdaq NM: IBIS), a leading provider of SIMOX-SOI
implantation equipment to the worldwide semiconductor industry, today
announced that on December 10, 2007 it received a letter from the
Nasdaq Stock Market advising that for the previous 30 consecutive
business days, the bid price of the Company's common stock (the
"Common Stock") had closed below the minimum $1.00 per share
requirement for continued inclusion on the Nasdaq Global Market
pursuant to Nasdaq Marketplace Rule 4450(a)(5). This notification has
no effect on the listing of the Common Stock at this time.

    Nasdaq stated in its letter that in accordance with Nasdaq
Marketplace Rule 4450(e)(2), the Company will be provided 180 calendar
days, or until June 9, 2008, to regain compliance with the minimum bid
price requirement. The bid price of the Common Stock must close at
$1.00 per share or more for a minimum of 10 consecutive business days
to achieve.

    If the Company does not regain compliance with the minimum bid
price requirement by June 9, 2008, the Nasdaq staff will provide the
Company with written notification that the Common Stock will be
delisted from the Nasdaq Global Market. At that time, the Company may
appeal the delisting determination to a Nasdaq Listings Qualifications
Panel pursuant to applicable Nasdaq rules. Alternatively, Nasdaq
Marketplace Rule 4450(i) may permit the Company to transfer the Common
Stock to the Nasdaq Capital Market if the Common Stock satisfies all
criteria, other than compliance with the minimum bid price
requirement, for initial inclusion on such market. In the event of
such a transfer, the Nasdaq Marketplace Rules provide that the Company
will be afforded an additional 180 calendar days to comply with the
minimum bid price requirement while listed on the Nasdaq Capital
Market.

    About Ibis Technology

    Ibis Technology Corporation is a leading provider of oxygen
implanters for the production of SIMOX-SOI
(Separation-by-Implantation-of-Oxygen Silicon-On-Insulator) wafers for
the worldwide semiconductor industry. Headquartered in Danvers,
Massachusetts, Ibis Technology is traded on Nasdaq under the symbol
IBIS. Information about Ibis Technology Corporation and SIMOX-SOI is
available on the Ibis web site at www.ibis.com.

    "Safe Harbor" Statement under the Private Securities Litigation
Reform Act of 1995

    This release contains express or implied forward-looking
statements including, among other things, (i) regaining compliance
with the minimum bid price requirement and the continued inclusion of
the Company's Common Stock on the Nasdaq Global Market or transfer to
the Nasdaq Capital Market, (ii) the Company's ability to conduct its
operations in a manner consistent with its current plan and existing
capital resources or otherwise to obtain additional implanter orders
or to secure financing to continue as a going concern, (iii) the
timing of SUMCO's ramping to production quantities on their i2000
implanters (iv) customer interest in and demand for, and market
acceptance of, the Company's SIMOX-SOI technology, (v) attaining
implanter improvements to the degree and in the timeframe necessary to
meet customer expectations, (vi) the Company's plan to focus on
supplying implanters to wafer manufacturers, (vii) the Company's
expectations regarding future orders for i2000 implanters, (viii) the
adequacy of the Company's cash resources for continuing and future
operations, and (ix) the adoption rate of SOI technology. Such
statements are neither promises nor guarantees, but rather are subject
to risks and uncertainties which could cause actual results to differ
materially from those described in the forward-looking statements.
Such risks and uncertainties include, but are not limited to,
cessation as a going concern due to the depletion of the Company's
cash reserves at an unanticipated rate combined with an inability to
obtain customer orders or to secure financing, future continued
migration to SOI technology and market acceptance of SIMOX, the level
of demand for the Company's products, the Company's ability to pursue
and maintain further strategic relationships, partnerships and
alliances with third parties, the Company's ability to protect its
proprietary technology, the potential trends in the semiconductor
industry generally, the ease with which an i2000 can be installed and
qualified in fabrication facilities, the likelihood that implanters,
if ordered, will be qualified and accepted by customers without
substantial delay, modification, or cancellation, in whole or in part,
the likelihood and timing of revenue recognition on such transactions,
the impact of competitive products, technologies and pricing, the
impact of rapidly changing technology, the possibility of further
asset impairment and resulting charges, equipment capacity and supply
constraints or difficulties, the Company's limited history in selling
implanters, general economic conditions, and other risks and
uncertainties described in the Company's Securities and Exchange
Commission filings from time to time, including but not limited to,
the Company's Annual Report on Form 10-K for the year ended December
31, 2006. All information set forth in this press release is as of
December 12, 2007, and Ibis undertakes no duty to update this
information unless required by law.


    CONTACT: Ibis Technology Corporation
             William J. Schmidt, 978-777-4247
             CFO & Treasurer